According to a Taiwanese cohort study, people with T2DM and COPD who require insulin therapy may be more likely to develop AECOPD, pneumonia, need to use a ventilator, and have severe hypoglycaemia; although they are not significantly more likely to die from the disease [71]. This evidence concerns the gene INS and chronic obstructive pulmonary disease.